CRP and lung disorder: Data from the Odense Schoolchild Study recently demonstrated that higher levels of CRP at age 20 are associated with greater reduction in FEV1 and FVC over nine years, but the young age of the study population makes it difficult to ascertain risk of future lung disease [10].